 |
Savient Pharma SVNT (news,
chart,
quote) - SVNT heavy option volume attributable to partnership chatter
SVNT is recently up $1.19 to $26.82. SVNT is the frequent subject of partnership chatter.
The FDA is expected to announce an outcome for SVNT's Puricase, the treatment-failure gout, in early 2009. SVNT call option volume of 3,987 contracts compares to put volume of 4,782 contracts. SVNT June option implied volatility is at 88, July is at 79 January 2009 is at 69. SVNT average option implied volatility over the last 23-weeks is 68 according to Track Data.
|
|
|
|
